Akimova 2011.
Methods | Double‐blind, longitudinal study. |
Participants | Patients with MDD. |
Interventions | Citalopram: 20mg/day. Escitalpram: 10mg/day. |
Outcomes | Alterations in different brain regions assessed with PET scans using the radioligand [11C]DASB. |
Notes |